Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
AML Electronic Decision Aid
ClinicalTrials.gov study NCT03442452. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
ClinicalTrials.gov study NCT00382954. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT01147939. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test
ClinicalTrials.gov study NCT06233526. IPD Sharing: NO. Countries: 1. Publications: 6.
Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00850382. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment
ClinicalTrials.gov study NCT04321161. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02864290. IPD Sharing: NO. Countries: 2. Publications: 1.
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
ClinicalTrials.gov study NCT01690065. IPD Sharing: Not stated. Countries: 1. Publications: 32.
CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML
ClinicalTrials.gov study NCT03384212. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Lentivirally Redirected CD123 Autologous T Cells in AML
ClinicalTrials.gov study NCT03766126. IPD Sharing: NO. Countries: 1. Publications: 1.
PET-CT in AML for Detection of Extramedullary AML Manifestations
ClinicalTrials.gov study NCT01278069. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML
ClinicalTrials.gov study NCT02140242. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
ClinicalTrials.gov study NCT05342584. IPD Sharing: NO. Countries: 1. Publications: 1.
Pyroptosis in AML
<p>This raw data is the materials and methods of performing pyroptosis in acute myeloid leukemia</p>
Supplementary material 2 from: Baskauf SJ, Girón Duque JC, Nielsen M, Cobb NS, Singer R, Seltmann KC, Kachian Z, Pérez M, Agosti D, Klompen AML (2023) Implementation Experience Report for Controlled Vocabularies Used with the Audubon Core Terms subjectPart and subjectOrientation. Biodiversity Information Science and Standards 7: e94188. https://doi.org/10.3897/biss.7.94188
Views Controlled Vocabularies Implementation Reporting Form
Supplementary material 1 from: Baskauf SJ, Girón Duque JC, Nielsen M, Cobb NS, Singer R, Seltmann KC, Kachian Z, Pérez M, Agosti D, Klompen AML (2023) Implementation Experience Report for Controlled Vocabularies Used with the Audubon Core Terms subjectPart and subjectOrientation. Biodiversity Information Science and Standards 7: e94188. https://doi.org/10.3897/biss.7.94188
Views Controlled Vocabularies testing notes
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
ClinicalTrials.gov study NCT06928376. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02249091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02003573. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04905407. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.